Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Sos2em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Sos2em1/Cya

Common Name
Sos2-KO
Product ID
S-KO-04419
Backgroud
C57BL/6JCya
Strain ID
KOCMP-20663-Sos2-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Sos2-KO Mouse (Catalog S-KO-04419) were purchased from Cyagen.”
KO Models
mTOR signaling pathway
ErbB signaling pathway
JAK-STAT signaling pathway
MAPK signaling pathway
PI3K-Akt signaling pathway
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
mTOR signaling pathway
ErbB signaling pathway
JAK-STAT signaling pathway
MAPK signaling pathway
PI3K-Akt signaling pathway
Basic Information
Strain Name
Sos2-KO
Strain ID
KOCMP-20663-Sos2-B6J-VA
Gene Name
Sos2
Product ID
S-KO-04419
Gene Alias
SOS-2, mSOS-2
Background
C57BL/6JCya
Gene Full Name
SOS Ras/Rho guanine nucleotide exchange factor 2
Modification
Conventional knockout
NCBI ID
20663 (Mouse)
Phenotype
MGI:98355
Chromosome
Chr 12 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000035773
NCBI Transcript ID
NM_001135559
Target Region
Exon 9~13
Size of Effective Region
~8.0 kb
Overview of Gene Research
Sos2, a member of the SOS family of Ras-GEFs along with its highly homologous counterpart SOS1, functions as a guanine nucleotide exchange factor for RAS proteins. It is involved in the regulation of multiple signaling pathways, such as the RAS-PI3K/AKT signaling axis, and plays important roles in various biological processes including cell growth, development, and homeostasis [1]. In plants, it is a key component of the Salt Overly Sensitive (SOS) pathway, which is crucial for maintaining sodium/potassium (Na+/K+) homeostasis under salt stress [2,4,5,7,8]. Genetic models, like KO mouse models, have been instrumental in understanding its functions.

Initial constitutive KO mouse studies showed that SOS1-KO mutants were embryonic lethal while SOS2-KO mice were viable, initially suggesting a more prominent role for SOS1 in linking external stimuli to downstream RAS signaling [1]. However, further genetic and pharmacological ablation studies revealed functional redundancy between SOS1 and SOS2, as the defective phenotypes in SOS1/2-DKO contexts were often much stronger than in single SOS1-KO scenarios and undetectable in single SOS2-KO cells [1]. In lung adenocarcinoma, SOS2 deletion (SOS2KO) sensitized EGFR-mutated cells to perturbations in EGFR signaling caused by reduced serum and/or osimertinib treatment, inhibiting PI3K/AKT pathway activation, oncogenic transformation, and survival, and also reduced osimertinib resistance associated with bypass RTK reactivation of PI3K/AKT signaling [6,9].

In plants, SOS2-related functional studies have shown its role in salt tolerance. For example, in Arabidopsis, SOS2 physically interacts with and phosphorylates PHYTOCHROME-INTERACTING FACTORS PIF1 and PIF3, decreasing their stability and relieving their repressive effect on plant salt tolerance [2]. Phosphatidic acid binds to SOS2 under salt stress, promoting its activity and plasma membrane localization, which in turn activates the Na+/H+ antiporter SOS1 to promote Na+ efflux, and also promotes the phosphorylation of SCaBP8 by SOS2, attenuating the SCaBP8-mediated inhibition of AKT1 to promote K+ influx [4]. The receptor-like kinase GSO1 activates SOS2 independently of SOS3 binding, forming a GSO1-SOS2-SOS1 module that protects the Arabidopsis root stem cell niche by enhancing sodium ion extrusion [5]. Rare missense variants in SOS2 have been associated with Noonan syndrome, expanding the molecular spectrum of RASopathies [3].

In conclusion, Sos2 has diverse functions in both mammalian and plant systems. In mammals, studies using KO mouse models have revealed its role in regulating the threshold of EGFR signaling and osimertinib resistance in lung adenocarcinoma. In plants, it is essential for maintaining Na+/K+ homeostasis and salt tolerance. These model-based studies have significantly enhanced our understanding of Sos2's functions and its implications in disease and plant stress responses.

References:
1. Baltanás, Fernando C, García-Navas, Rósula, Santos, Eugenio. 2021. SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology. In International journal of molecular sciences, 22, . doi:10.3390/ijms22126613. https://pubmed.ncbi.nlm.nih.gov/34205562/
2. Ma, Liang, Han, Run, Yang, Yongqing, Li, Jigang, Guo, Yan. . Phytochromes enhance SOS2-mediated PIF1 and PIF3 phosphorylation and degradation to promote Arabidopsis salt tolerance. In The Plant cell, 35, 2997-3020. doi:10.1093/plcell/koad117. https://pubmed.ncbi.nlm.nih.gov/37119239/
3. Yamamoto, Guilherme Lopes, Aguena, Meire, Gos, Monika, Passos-Bueno, Maria Rita, Bertola, Débora Romeo. 2015. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. In Journal of medical genetics, 52, 413-21. doi:10.1136/jmedgenet-2015-103018. https://pubmed.ncbi.nlm.nih.gov/25795793/
4. Li, Jianfang, Shen, Like, Han, Xiuli, Zhang, Wenhua, Guo, Yan. 2023. Phosphatidic acid-regulated SOS2 controls sodium and potassium homeostasis in Arabidopsis under salt stress. In The EMBO journal, 42, e112401. doi:10.15252/embj.2022112401. https://pubmed.ncbi.nlm.nih.gov/36811145/
5. Chen, Changxi, He, Gefeng, Li, Jianfang, Kudla, Jörg, Guo, Yan. 2023. A salt stress-activated GSO1-SOS2-SOS1 module protects the Arabidopsis root stem cell niche by enhancing sodium ion extrusion. In The EMBO journal, 42, e113004. doi:10.15252/embj.2022113004. https://pubmed.ncbi.nlm.nih.gov/37211994/
6. Theard, Patricia L, Linke, Amanda J, Sealover, Nancy E, Cox, Katherine, Kortum, Robert L. 2023. SOS2 regulates the threshold of mutant EGFR-dependent oncogenesis. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.01.20.524989. https://pubmed.ncbi.nlm.nih.gov/37425733/
7. Zhu, Jian-Kang. . Salt and drought stress signal transduction in plants. In Annual review of plant biology, 53, 247-73. doi:. https://pubmed.ncbi.nlm.nih.gov/12221975/
8. Bertorello, Alejandro Mario, Zhu, Jian-Kang. 2009. SIK1/SOS2 networks: decoding sodium signals via calcium-responsive protein kinase pathways. In Pflugers Archiv : European journal of physiology, 458, 613-9. doi:10.1007/s00424-009-0646-2. https://pubmed.ncbi.nlm.nih.gov/19247687/
9. Theard, Patricia L, Linke, Amanda J, Sealover, Nancy E, Cox, Katherine, Kortum, Robert L. 2024. SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma. In Molecular oncology, 18, 641-661. doi:10.1002/1878-0261.13564. https://pubmed.ncbi.nlm.nih.gov/38073064/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research